Authors: Lankhuizen, IM van Veghel, R Saxena, PR Schoemaker, RG

Citation: Im. Lankhuizen et al., Vascular and renal effects of vasopressin and its antagonists in consciousrats with chronic myocardial infarction; evidence for receptor shift, EUR J PHARM, 423(2-3), 2001, pp. 195-202

Authors: Bijsterbosch, MK Rump, ET De Vrueh, RLA Dorland, R van Veghel, R Tivel, KL Biessen, EAL van Berkel, TJC Manoharan, M

Citation: Mk. Bijsterbosch et al., Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation, NUCL ACID R, 28(14), 2000, pp. 2717-2725

Authors: Lankhuizen, IM van Veghel, R Saxena, PR Schoemaker, RG

Citation: Im. Lankhuizen et al., [Arg(8)]-vasopressin-induced responses on coronary and mesenteric arteriesof rats with myocardial infarction: The effects of V-1a- and V-2-receptor antagonists, J CARDIO PH, 36(1), 2000, pp. 38-44

Authors: de Vrueh, RLA Rump, ET van de Bilt, E van Veghel, R Balzarini, J Biessen, EAL van Berkel, TJC Bijsterbosch, MK

Citation: Rla. De Vrueh et al., Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B, ANTIM AG CH, 44(3), 2000, pp. 477-483

Authors: Rump, ET de Vrueh, RLA Manoharan, M Waarlo, IHE van Veghel, R Biessen, EAL van Berkel, TJC Bijsterbosch, MK

Citation: Et. Rump et al., Modification of the plasma clearance and liver uptake of steroid ester-conjugated oligodeoxynucleotides by association with (lactosylated) low-density lipoprotein, BIOCH PHARM, 59(11), 2000, pp. 1407-1416

Authors: Fechner, H Haack, A Wang, H Wang, X Eizema, K Pauschinger, M Schoemaker, RG van Veghel, R Houtsmuller, AB Schultheiss, HP Lamers, JMJ Poller, W

Citation: H. Fechner et al., Expression of Coxsackie adenovirus receptor and alpha(v)-integrin does notcorrelate with adenovector targeting in vivo indicating anatomical vector barriers, GENE THER, 6(9), 1999, pp. 1520-1535